John Desjarlais
Equibles does not estimate personal net worth.
Get an email with a short summary when Xencor Inc publishes a filing, an earnings call transcript or a press release.
Get XNCR alertsAbout John Desjarlais
The proxy statement of Xencor Inc reports total compensation of $1,982,252 for John Desjarlais in fiscal 2025, including a base salary of $547,900. Disclosed compensation is on record for 6 fiscal years. Xencor Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xencor Inc includes Dr. Bassil I. Dahiyat (CEO and Board Member), Bart Cornelissen (CFO), Bart Jan Cornelissen (CFO) and 7 others.
Affiliation history
-
Xencor Inc (XNCR)
Proxy statement
CurrentStart not stated–present
Last confirmed April 27, 2026
Company network
Leadership on record at Xencor Inc
- Dr. Bassil I. Dahiyat CEO, Board Member
- Bart Cornelissen CFO
- Bart Jan Cornelissen CFO
- Celia E. Eckert General Counsel
- Barbara Klencke, M.D. Board Member
- Dr. A. Bruce Montgomery Board Member
- Dr. Barbara Klencke Board Member
- Dr. Ellen G. Feigal Board Member
- Dr. Kevin C. Gorman Board Member
- Dr. Raymond J. Deshaies Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xencor Inc (XNCR) | Chief Scientific Officer | $547,900 | $1,982,252 |
| 2024 | Xencor Inc (XNCR) | Chief Scientific Officer | $534,500 | $2,827,992 |
| 2023 | Xencor Inc (XNCR) | Chief Scientific Officer | $518,900 | $3,213,094 |
| 2022 | Xencor Inc (XNCR) | Chief Scientific Officer | $485,000 | $2,955,047 |
| 2021 | Xencor Inc (XNCR) | Chief Scientific Officer | $465,000 | $2,625,325 |
| 2020 | Xencor Inc (XNCR) | Chief Scientific Officer | $437,000 | $1,870,907 |
Recent activity
No call appearances or filed executive changes recorded yet.